A number of social networking site Facebook pages reported a program through which a Sudanese actress, who has achieved great fame recently, was hosted. According to what the editor of Al-Neelain website witnessed, the program whose idea came as a hidden camera prank program without the knowledge of the guest of the program. Actress Kholoud Abu Bakr, who was the guest of the episode, showed her other side (…)
Category:
Rise in hepatitis cases in children: New studies provide insight
written by Alexandra Hartman Editor-in-Chief
Hepatitis is inflammation of the liver. Usually, this rarely occurs – especially in the Global North – and runs smoothly with competent medical treatment.
But last year there was a wave of children’s hepatitis, which caused many parents to worry. In July, the WHO announced that over 1,000 children had developed hepatitis. The “small pandemic” of hepatitis spread to 35 countries.
More than 30 children have required liver transplants, and 22 patients have even died from the disease. Scientific research is now providing some insight as to why this might have happened.
This mysterious and massive occurrence of childhood hepatitis has been investigated by various studies. These were published in the magazine “Nature” and show that the researchers see a connection to the adeno-associated virus 2. This virus was found in high concentrations in the sick children.
What is surprising regarding this is that it was actually assumed that this virus cannot cause diseases. Accordingly, the studies assume possible “helper viruses” that contribute to the severity of hepatitis.
The studies also do not rule out that this wave of hepatitis in children might be a consequence of the corona virus. After all, this occurred immediately following the relaxation of the corona measures.
Frank Tacke from the Berlin Charité explains to the news portal “Science.orf.at”: “It might be an unintended consequence of what we have experienced in the last two to three years of the pandemic.”
The wave of hepatitis has now subsided. Nevertheless, it is recommended to continue to adhere to the hygiene regulations, the heads of the studies say.
“We had no guarantees if I would get out of this alive”
written by Alexandra Hartman Editor-in-Chief
This Monday, from his platform in “Milf” on TV+, Fran Conservessister of Claudia Preservesrevealed new details of the documentary series that the animator is preparing around her cancer treatment.
Last week, within the framework of the launch of the TVN programming for this 2023, the first images of “Brava”a non-fiction program where Conserva will narrate in first person the ravages of the diagnosis.
“Equally, I don’t want to speak before her, I feel that she has to give her reasons, her reasons. I can only tell you, from my sidewalk, that I am quite involved in the project”commented Fran, who took on work “behind the camera.”
“I recorded it, edited it, and just to say that it is not intended to be a news program for people with cancer or anything (…). It is a very honest record”, he added, while assuring that the idea came from Claudia herself.
“She started recording before. We had no guarantee if Claudia would get out of this alive or not. We recorded with her health very much once morest her… It was a process where she got rid of all her vanity, and she showed herself as she is, ”she said.
“From my point of view, that I know the material, it is interesting to see it. At times very raw, at times dealing with a sisterly mood, sometimes black, sometimes white. Crying, laughing… It was like a roller coaster.”summarized.
“I feel that many people are going to feel identified, because like no one shows themselves in bad times, leaving the ego behind (…). Deep down, it is the disaster that remains familiarly, because (cancer) does not affect only one person. I can only say that it is precious, honest material, made with a lot of love”, she added.
L’Oréal buys Australian luxury cosmetics brand Aesop, valued at $2.5 billion
written by Alexandra Hartman Editor-in-Chief
The Aesop brand achieved sales of $537 million in 2022, according to a statement, and is so far owned by Brazilian group Natura &Co (The Body Shop, Avon). “Aēsop is taking advantage of all ‘carrying’ consumer trends and L’Oréal will help accelerate its enormous growth potential”, particularly in China, says L’Oréal Managing Director Nicolas Hieronimus.
“We are convinced that Aēsop will join the club of billionaire brands in the Division, thus contributing significantly to the growth of L’Oréal Luxe in the years to come”, adds Cyril Chapuy, President of L’Oréal Luxe also quoted in the press release and who “is delighted to welcome Michael O’Keeffe, Managing Director of Aēsop, and his teams”.
The L’Oréal Luxe category (Lancôme, Yves Saint Laurent, Giorgio Armani, etc.) occupied first place for the second consecutive year in 2022 within the group’s various divisions with 14.6 billion euros in sales (+18 .6%).
Fábio Barbosa, Managing Director of Natura &Co, explains in the press release that “the sale of Aēsop marks the start of a new cycle of development for Natura &Co”. “With a strengthened financial structure, a healthy balance sheet, and strict financial discipline, Natura &Co will be able to focus more on its strategic priorities, in particular on its investment plan in Latin America”, he said. The group wants to “continue to focus on strengthening The Body Shop and refocusing the footprint of Avon International”.
Founded in 1987, Aesop is known for its skin, hair and body products. Identified with its “iconic amber packaging, sustainable vegan formulas, natural ingredients, and personalized customer service, Aēsop has become a global brand available in high-end boutiques, beauty centers and luxury hotels around the world”, according to the press release.
Aesop is distributed through approximately 400 exclusive outlets in America, Europe, Australia, New Zealand and Asia, with a budding presence in China where the first store opened in 2022.
L’Oréal, the world’s number one cosmetics company, achieved a 24.1% increase in net profit in 2022 to 5.7 billion euros and an 18.5% increase in sales to 38.3 billion. euros.